# Inhaled

## Length of Authorizations

28 Days

## Prior Authorization Criteria

Is there any reason the patient cannot be changed to a medication not requiring prior approval? Acceptable reasons include:

-   Allergy to medications not requiring prior approval
-   Contraindication to or drug interaction with medications not requiring prior approval
-   History of unacceptable/toxic side effects to medications not requiring prior approval
-   Diagnosis of cystic fibrosis with pseudomonas-related infection
-   Age limit of 6 and older for tobramycin products
-   Age limit of 7 and older for aztreonam
-   “Pulse” dosing cycles of 28 days on drug, followed by 28 days off drug

## Additional Criteria

### Information

The requested medication may be approved if the following is true:

-   If there has been no less than a **28-day** trial of at least **one preferred** medication

### Amikacin

Additional Criteria for Amikacin

#### Length Of Authorizations

Initial authorization 180 days

Subsequent authorizations 365 days

1.  Clinical criteria for initial authorization:
    -   Diagnosis of *Mycobacterium avium* complex (MAC) lung disease; and
    -   Patient has not achieved negative sputum cultures after a minimum of 180 consecutive days of a multidrug background regimen therapy (e.g. macrolide, rifampin, & ethambutol)
2.  Criteria for subsequent authorizations
    -   Evidence of culture conversion (negative sputum culture)
3.  Dose will be limited to 1 dose per day

## Formulary

Infectious Disease Agents: Antibiotics – Inhaled

| PREFERRED        | NON-PREFERRED    |
|------------------|------------------|
| Arikayce PA QL   | Bethkis AR       |
| Tobramycin AR PA | Cayston AR       |
|                  | Kitabis Pak AR   |
|                  | Tobi Podhaler AR |

## Links

[Criteria](https://pharmacy.medicaid.ohio.gov/sites/default/files/20220415_UPDL_Criteria_FINAL_.pdf#page=74)

[Preferred Drug List](https://pharmacy.medicaid.ohio.gov/sites/default/files/20220701_UPDL_FINAL.pdf#page=25)
